Evaluation of SofWave Sofware-Guided Energy Delivery for Lower Face and Neck Rejuvenation
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Sofwave Medical LTD
- Study ID
- NCT07723664
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Facial Wrinkles
- Jawline Contour
- Skin Laxity
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 55 Years
- Healthy Volunteers
- Accepted
Interventions
- SofWave — DEVICEThe Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues
Study Details
Non-randomized single-arm prospective clinical study.
Key Dates
- First listed
- Jul 23, 2026
- Start date
- Jul 20, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 15, 2027
- Completion
- Jul 15, 2027
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Experimental: lax tissue
Primary Outcome Measure
Evaluate the clinical efficacy of the treatment for lower face and upper neck rejuvenation [ Time Frame: 12 weeks post treatment follow-up visit ]
Central Contacts
- Shlomit Mann, MSc+972-4-7800268
- Ruthie Amir, MD+972-4-300-3164
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Dermatology & Laser Surgery Center | Houston | Texas | 77004 | Paul Friedman, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site
Related Studies
- Evaluation of Fractional Ablative Laser Treatment for Skin ConditionsRecruiting · Sciton · Boca Raton, Florida
- Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor AgonistsRecruiting · Cytrellis Biosystems, Inc. · Dublin, California
- A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive ImagingRecruiting · Galderma R&D · New York, New York